Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis

Amyloid

Volumn 18, Issue SUPPL. 1, 2011, Pages 132-134

  Binotto, G ^a   Cillo, U ^a   Trentin, L ^a   Piazza, F ^a   Zaninotto, M ^a   Semenzato, G ^a   Adami, Fausto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMYLOID; BENCE JONES PROTEIN; BILIRUBIN; BORTEZOMIB; DEXAMETHASONE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; LENALIDOMIDE; MELPHALAN; THALIDOMIDE;

ADULT; ALBUMINURIA; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLOIDOSIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BILIRUBIN BLOOD LEVEL; CARDIOTOXICITY; CASE REPORT; CD34 SELECTION; CELL INFILTRATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DYSPEPSIA; FEMALE; HEPATOMEGALY; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTROPHORESIS; LIGHT CHAIN AMYLOIDOSIS; LIVER BIOPSY; LIVER FAILURE; LIVER SIZE; LIVER TRANSPLANTATION; PLASMA CELL; PRIORITY JOURNAL; STEM CELL MOBILIZATION; TREATMENT RESPONSE; WEIGHT REDUCTION;

EID: 79959974693     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2011.574354     Document Type: Article

References (10)

1. Gertz MA, Kyle RA, O'Fallon WM. Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients. Arch Intern Med 1992;152:2245-2250.
2. Bollée G, Guery B, Joly D, Snanoudj R, Terrier B, Allouache M, Mercadal L, Peraldi MN, Viron B, Fumeron C, et al. Presentation and outcome of patients with systemic amyloidosis undergoing dialysis. Clin J Am Soc Nephrol 2008;3:375-381.
3. Leung N, Griffin MD, Dispenzieri A, Haugen EN, Gloor JM, Schwab TR, Textor SC, Lacy MQ, Litzow MR, Cosio FG, et al. Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement. Am J Transplant 2005;5:1660-1670. (Pubitemid 40910448)
4. Casserly LF, Fadia A, Sanchorawala V, Seldin DC, Wright DG, Skinner M, Dember LM. High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease. Kidney Int 2003;63:1051-1057. (Pubitemid 36315584)
5. Hall R, Hawkins PN. Cardiac transplantation for AL amyloidosis. BMJ 1994;309:1135-1137. (Pubitemid 24324858)
6. Dubrey SW, Burke MM, Hawkins PN, Banner NR. Cardiac transplantation for amyloid heart disease: the United Kingdom experience. J Heart Lung Transplant 2004;23:1142-1153. (Pubitemid 39346230)
7. Gillmore JD, Goodman HJ, Lachmann HJ, Offer M, Wechalekar AD, Joshi J, Pepys MB, Hawkins PN. Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis. Blood 2006;107:1227-1229. (Pubitemid 43156329)
8. Gillmore JD, Stangou AJ, Lachmann HJ, Goodman HJ, Wechalekar AD, Acheson J, Tennent GA, Bybee A, Gilbertson J, Rowczenio D, et al. Organ transplantation in hereditary apolipoprotein AI amyloidosis. Am J Transplant 2006;6:2342-2347. (Pubitemid 44359419)
9. Nowak G, Westermark P, Wernerson A, Herlenius G, Sletten K, Ericzon BG. Liver transplantation as rescue treatment in a patient with primary AL kappa amyloidosis. Transpl Int 2000;13:92-97. (Pubitemid 30417363)
10. Kumar KS, Lefkowitch J, Russo MW, Hesdorffer C, Kinkhabwala M, Kapur S, Emond JC, Brown RS, Jr. Successful sequential liver and stem cell transplantation for hepatic failure due to primary AL amyloidosis. Gastroenterology 2002;122:2026-2031. (Pubitemid 34651444)